Brazilian antitrust watchdog CADE approved with no restriction the takeover of medical diagnostics company Alliar by an investment fund linked to tycoon Nelson Tanure, the country’s official gazette showed on Friday.
Controlling shareholders of Alliar announced in November they had accepted Tanure’s bid of 20.50 reais ($3.76) per share in the company, formally known as Centro de Imagem Diagnosticos SA.
Alliar said in a securities filing that CADE’s decision will be binding after a 15-day period starting on Friday, provided there are no challenges to the body’s ruling on the transaction.
Still, the closing of the deal depends on “the completion of other normal conditions precedent for this type of transaction,” it added.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
